drugset / Trial / NCT00057343
Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to provide treatment for patients who have relapsed NHL or refractory NHL, and to determine the effectiveness and safety of the Zevalin and Rituxan regimens or Rituxan therapy alone on your disease.
Timeline
- Start
- 2003-03
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rituximab | Monoclonal antibody | — | — |
| Subject | ibritumomab tiuxetan | Monoclonal antibody | — | — |